National Institutes of Health

BioHealth names Chappell first entrepreneur-in-residence

Tuesday, March 27, 2012 06:01 AM

BioHealth Innovation (BHI), a new regional private-public partnership, has selected Todd Chappell as the first entrepreneur-in-residence for BHI at the National Institutes of Health (NIH) Office of Technology Transfer (OTT).

More... »

FDA approves clinical trial of artificial pancreas

Monday, March 19, 2012 03:46 PM

The FDA has approved the first outpatient artificial pancreas trial in the U.S., which will be funded by JDRF, a global organization focused on type 1 diabetes research.

More... »

Columbia, Weill Cornell join national effort to spur clinical trials in neurosciences

Friday, March 16, 2012 11:49 AM

The National Institute for Neurological Disorders and Stroke (NINDS) has selected Columbia University College of Physicians and Surgeons and Weill Cornell Medical College to participate in a new national effort to accelerate the development of therapies for people with neurological diseases.

More... »

Trovagene names new vice president

Friday, February 17, 2012 12:46 PM

Trovagene, a developer of transrenal molecular diagnostics, has named Charlie Rodi, Ph.D., vice president and chief technology officer.

More... »

NIH to join multi-center trial of new tuberculosis vaccine

Tuesday, February 7, 2012 07:34 AM

The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), has joined a phase II proof-of-concept clinical trial of a tuberculosis (TB) vaccine candidate jointly developed by Aeras and Dutch biopharmaceutical company Crucell.

More... »

HemoShear appoints Figler scientific director

Monday, February 6, 2012 02:50 PM

HemoShear, a biotechnology research company, has appointed Robert A. Figler, Ph.D., scientific director.

More... »

Aphios awarded SBIR grant for Alzheimer’s research

Wednesday, January 25, 2012 04:12 PM

Aphios has received a phase II SBIR grant from the National Institutes of Health (NIH) for $2.4 million over two years. The National Institute on Aging (NIA), part of the NIH, awarded the grant to Aphios to develop an “Alzheimer’s Disease Therapeutic.

More... »

Sequenom names Huang to ophthalmology advisory board

Tuesday, October 25, 2011 02:47 PM

Sequenom, a life sciences company providing innovative genetic analysis solutions, has named Suber Huang, M.D., to its ophthalmology clinical advisory board.

More... »

GeoVax completes enrollment for HVTN 205 trial

Monday, October 3, 2011 11:05 AM

GeoVax Labs has completed enrollment for a phase IIa clinical trial testing its HIV/AIDS vaccine. The vaccine is being developed for use in uninfected people to prevent infection should they be exposed to the virus. The trial, designated HVTN 205, is being conducted by the HIV Vaccines Trials Network (HVTN), which is funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. A total of 299 participants are enrolled in HVTN 205.

More... »

EU Clinical Trials Register to be available on WHO’s ICTRP portal

Thursday, September 22, 2011 02:13 PM

The European Union Clinical Trials Register (EU-CTR) has been recognized as one of the primary registries for the World Health Organization’s (WHO) International Clinical Trials Registry Platform (ICTRP), according to PharmaTimes.

More... »